In human oral cancer OC2 cells in vitro, BITC inhibits growth and triggers apoptosis by reducing Mcl-1 and Bcl-2 expression and increased PARP cleavage (33). This evidence concerns the gene BCL2 and lip and oral cavity carcinoma.